Drugs / Rabies Vaccine（MRC-5 Cell)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02281396 | Nov 2014 → Jan 2015 | rabies | Beijing Center for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02288286 | Nov 2014 → Feb 2015 | — | Beijing Center for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabies Vaccine（MRC-5 Cell) | “Freeze-dried Rabies Vaccine（MRC-5 Cell) of 2.5IU/ml,5 doses,4 weeks interval” NCT02281396 ↗ |
| Modality | Vaccine | “Freeze-dried Rabies Vaccine （MRC-5 Cell) in healthy humans aged from 10-60 years old” NCT02281396 ↗ |